Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
Crossref DOI link: https://doi.org/10.1007/s41669-018-0107-y
Published Online: 2018-11-26
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Landfeldt, Erik http://orcid.org/0000-0002-5758-7151
Text and Data Mining valid from 2018-11-26
Article History
First Online: 26 November 2018
Compliance with ethical standards
:
: None.
: Dr. Erik Landfeldt conducts research for pharmaceutical companies marketing treatments for DMD.